Gregory Daniel, PhD, MPH is the Deputy Director of the Duke-Robert J. Margolis, MD Center for Health Policy and a Clinical Professor in Duke's Fuqua School of Business. He directs the DC-based office of the Center leading its pharmaceutical and medical device policy portfolio, and is also an Adjunct Associate Professor at the UNC Eshelman School of Pharmacy. Dr. Daniel’s research expertise includes RWE development utilizing electronic health data in the areas of health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology. He received a PhD in pharmaceutical economics, policy and outcomes from the University of Arizona, and an MPH, MS, and BS in Pharmacy all from The Ohio State University.